SCHEMBL13744249

SCHEMBL13744249

N#Cc1ccccc1OCC(=O)Nc1ccccc1

nearest known ligand 0.74

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NOTUM Q6P988 2/20 0.74
SMN1; SMN2 Q16637 4/20 0.66
GAA P10253 1/20 0.66
NPC1 O15118 9/20 0.65
RAB9A P51151 8/20 0.65
MAPK1 P28482 1/20 0.64
KMT2A Q03164 1/20 0.62
TDP1 Q9NUW8 1/20 0.62
ALDH1A1 P00352 4/20 0.61
KDM4E B2RXH2 1/20 0.59
TP53 P04637 1/20 0.59
NPSR1 Q6W5P4 1/20 0.59
HCRTR1 O43613 1/20 0.57
LMNA P02545 1/20 0.57
HTT P42858 1/20 0.57
HPGD P15428 1/20 0.56
TSHR P16473 1/20 0.56
L3MBTL1 Q9Y468 1/20 0.54
NPY1R P25929 1/20 0.53
NPY2R P49146 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13515794 0.90 NOTUM (0.66) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL13665153 0.89 NOTUM (0.65) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL2949440 0.89 HPGD (0.67) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL13665156 0.89 NOTUM (0.65) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL13744734 0.87 NPC1 (0.67) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL26334075 0.85 SMN1; SMN2 (0.69) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL4910951 0.82 SMN1; SMN2 (0.59) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL10153796 0.82 SMN1; SMN2 (0.72) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL1279945 0.81 SMN1; SMN2 (0.63) NOTUMSMN1; SMN2GAANPC1RAB9A
SCHEMBL7000350 0.79 RAB9A (0.80) NOTUMSMN1; SMN2GAANPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed
US-7531537-B2 Benzofuran derivative MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-05-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 NOTUM 3255/4885SMN1; SMN2 3067/4885GAA 3844/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.